Medication info

Duygen Tablet 60/5 mg (Pimodartan Potassium Trihydrate, Esamlodipine Besylate)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›7.48mg / 1 tablet
Manufacturer / importer
CTC Bio Co., Ltd.
Appearance
Orange, rounded-edge rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202300104 · Approved 2023.01.06 · Insurance code 669502730

This product's status changed to Approval withdrawn on 2025.08.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted with fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required in elderly patients aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 milligrams. No dose adjustment is required in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Ingredients

Manufacturer
CTC Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with pimodartan potassium. It effectively lowers blood pressure and helps prevent cardiovascular complications.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted with fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required in elderly patients aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 milligrams. No dose adjustment is required in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Precautions

This drug can cause serious harm or death to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to patients who are allergic to any ingredients of this drug, those who are pregnant or breastfeeding, those undergoing renal dialysis, those with moderate to severe liver function impairment, those with bile duct obstruction, patients with certain renal or diabetes-related diseases, patients with lactose intolerance or other genetic issues, and patients with severe aortic stenosis or in shock. Caution should be exercised when administering this drug to patients with reduced blood volume or sodium, impaired renal function, renal artery hypertension, aortic and mitral stenosis or obstructive/hypertrophic cardiomyopathy, primary aldosteronism, severe hypotension, elderly patients, and patients with known allergies to specific pigments. Dizziness, headache, facial swelling, urinary disturbances, insomnia, flushing, and other unusual symptoms may occur during treatment, and consultation with a healthcare professional is recommended if these symptoms arise. This medication lowers blood pressure and care should be taken in patients at risk of excessive hypotension or electrolyte imbalances. Regular monitoring of blood pressure and laboratory tests may be necessary. It may interact with other antihypertensive drugs, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory analgesics and should be communicated to healthcare providers if other medications are being taken. Women who are pregnant or breastfeeding should consult a physician before taking this medication, and breastfeeding should be stopped if they continue medication. The safety of this drug in children under 18 years has not been established, and caution is required in patients aged 70 and above as they may be more sensitive to the effects. Patients with severe liver impairment should not take this medication. Overdose may result in hypotension, arrhythmias, severe vascular dilation, and appropriate medical treatment should be sought immediately if overdose is suspected. This medication should be kept out of reach of children, and transferring it to another container may compromise its quality.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • micturition disorder
  • insomnia
  • flushing
  • fainting
  • sedation
Show 125 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • pruritus
  • localized urticaria
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • cerebral infarction deterioration
  • cerebral hemorrhage
  • liver cancer
  • colon carcinoma
  • neoplasm of unknown origin
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • increased blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • pelvic organ prolapse
  • recurrent cancer
  • chest pain
  • low back pain
  • fatigue
  • fever
  • neck/shoulder pain
  • fracture
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • nosebleed
  • bronchitis
  • paresthesia
  • numbness
  • tremor
  • hypertonia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • appetite loss
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional bowel disorder
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • purpura
  • urticaria
  • toxic epidermal necrolysis
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • rash
  • vascular edema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • blood pressure reduction
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • epigastric pain
  • diarrhea
  • loose stools
  • skin hyperemia
  • maculopapular rash
  • heaviness
  • warmth
  • decreased glucose tolerance
  • frailty

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. It should also be kept at a temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Orange, rounded-edge rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.